• 1. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyridines Imidazopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyridines

Comprehensive Overview of 8-Bromo-6-methylimidazo[1,2-a]pyridine (CAS No. 136117-93-6): Properties, Applications, and Research Insights

8-Bromo-6-methylimidazo[1,2-a]pyridine (CAS No. 136117-93-6) is a heterocyclic organic compound that has garnered significant attention in pharmaceutical and agrochemical research due to its unique structural features. The imidazo[1,2-a]pyridine scaffold is a privileged structure in medicinal chemistry, often associated with bioactive molecules targeting various diseases. This article delves into the compound's properties, synthesis, applications, and its relevance in contemporary scientific discussions, including drug discovery and AI-driven molecular design.

The molecular formula of 8-Bromo-6-methylimidazo[1,2-a]pyridine is C₈H₇BrN₂, with a molecular weight of 211.06 g/mol. Its structure combines a bromine substituent at the 8-position and a methyl group at the 6-position, which are critical for modulating electronic and steric properties. Researchers frequently explore such modifications to optimize pharmacokinetic profiles or enhance binding affinity to biological targets. The compound's lipophilicity and hydrogen-bonding capacity make it a versatile intermediate in synthetic chemistry.

In recent years, the demand for imidazo[1,2-a]pyridine derivatives has surged, driven by their potential in treating neurological disorders and infectious diseases. For instance, analogs of this scaffold have shown promise as GABA_A receptor modulators and antiviral agents. A 2023 study highlighted its role in designing COVID-19 protease inhibitors, aligning with the global focus on pandemic preparedness. Such applications underscore the compound's relevance in high-throughput screening and fragment-based drug design.

Synthetic routes to 8-Bromo-6-methylimidazo[1,2-a]pyridine typically involve cyclization reactions of 2-aminopyridines with α-bromoketones or via palladium-catalyzed cross-coupling. Innovations in green chemistry have also introduced solvent-free or catalytic methods to improve yield and sustainability—a topic trending in ESG-focused research. These advancements address growing user queries about eco-friendly synthesis and cost-effective scaling in pharmaceutical manufacturing.

Beyond therapeutics, CAS No. 136117-93-6 is explored in material science, particularly in developing organic semiconductors and fluorescent probes. Its π-conjugated system and bromine atom enable facile functionalization, making it a candidate for OLEDs or bioimaging tools. This multidisciplinary utility resonates with searches for multi-functional chemicals and cross-industry innovations.

Quality control of 8-Bromo-6-methylimidazo[1,2-a]pyridine relies on techniques like HPLC, NMR, and mass spectrometry. Purity (>98%) is crucial for reproducibility in research, a concern frequently raised in online forums and scientific communities. Suppliers often provide COA (Certificate of Analysis) to meet stringent ISO standards, addressing user priorities around reliable sourcing and regulatory compliance.

In summary, 8-Bromo-6-methylimidazo[1,2-a]pyridine exemplifies the intersection of traditional organic chemistry and cutting-edge applications. Its adaptability to AI-augmented drug design and alignment with sustainable chemistry trends position it as a compound of enduring scientific and industrial value. Future research may unlock further roles in precision medicine or smart materials, answering the growing curiosity around next-generation chemical entities.

• 6188-23-4(6-Bromoimidazo[1,2-a]pyridine)
• 1216231-53-6(6-Bromo-2,8-dimethylimidazo1,2-apyridine)
• 850349-02-9(8-Bromoimidazo[1,2-a]pyridine)
• 217435-65-9(6-Bromo-8-methylimidazo[1,2-a]pyridine)
• 1072944-58-1(3,8-Dibromo-6-methylimidazo1,2-apyridine)
• 957035-22-2(6-Bromo-7-methylimidazo1,2-apyridine hydrochloride)
• 957120-41-1(8-Bromo-6-methylimidazo1,2-apyridine hydrochloride)
• 116355-18-1(6-Bromo-7-methylimidazo[1,2-a]pyridine)
• 604009-01-0(6-Bromoimidazo[1,2-a]pyridine hydrobromide)
• 847446-51-9(8-Bromo-2,6-dimethylimidazo[1,2-a]pyridine)